Peter Lebowitz
Patrimonio netto: - $ in data 31/05/2026
Patrimonio netto: - $ in data 31/05/2026
Dr. Peter F.
Lebowitz is an Independent Director at Bridgebio Oncology Therapeutics, Inc., an Independent Director at Bridgebio Oncology Therapeutics, Inc. /New/, a Chief Executive & Medical Officer, Director at Third Arc Bio, Inc. and a Head-Oncology Therapeutic Area at Janssen Research & Development LLC.
He is on the Board of Directors at Bridgebio Oncology Therapeutics, Inc., Bridgebio Oncology Therapeutics, Inc. /New/ and Third Arc Bio, Inc. Dr. Lebowitz was previously employed as a Chief Executive Officer by Aragon Pharmaceuticals, Inc.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
-.--% | 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 2 |
|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale